Clinical Development

Beyond the standard laboratory tests performed in the course of clinical studies, the evaluation of advanced-therapy medicinal products and DNA-based vaccines required a set of specific analysis that are not supported by most hospitals or CROs.

As experts in the evaluation of gene and cell therapy products, we offer a large portfolio of specific assays in different domains (Virological assays, immunological assays) for the follow-up of patients enrolled in clinical trials.

Our clients can benefit from the development of the methods and information obtained during the non clinical phase of their project in order to succeed and accelerate the transition to the clinical trial.